January 11, 2023
Miki Yamamoto, PhD, is the vice president and head of regulatory affairs at Arrivent Biopharma. Yamamoto is joining the QB3-Berkeley Professionals in Residence (PIR) program on February 9th 2023. UC…
November 15, 2022
Katja Brose, PhD, is a science program officer at the Chan Zuckerberg Initiative (CZI). Brose is joining the QB3-Berkeley Professionals in Residence (PIR) program on January 26th, 2023. UC Berkeley…
April 26, 2022
Seth Lieblich, PhD, is a principal at venture capital firm 8VC focusing on life sciences technologies. He joins the QB3-Berkeley Professional in Residence program on May 6th. Lieblich spoke to…
March 29, 2022
Timothy Day, PhD and UC Berkeley alumnus, is the co-founder and chief scientific officer (CSO) of DNALite Therapeutics. Day will be QB3-Berkeley’s Professional in Residence on April 5, 2022. In…
February 23, 2022
While graduate students in the College of Chemistry have long been leading DEI efforts and initiatives to improve the unit’s climate, a new program provides more support and compensation for…
January 24, 2022
Christopher Hann-Soden discusses the breadth of services offered at UC Berkeley’s QB3 Genomics Core Facility. The QB3 Genomics core research facility is an umbrella term for three separate UC Berkeley…
January 18, 2022
UC Berkeley research strives to understand the cell’s complex recycling program and how we can use it to treat diseases. Our bodies are composed of trillions of cells—each one equipped…
January 05, 2022
Elise Kikis, PhD, is a professor of biology and chair of the biology department at the University of the South (Sewanee). Kikis is joining the QB3-Berkeley Professionals in Residence (PIR)…